EE200200374A - Enoksapariini kasutamine ajuisheemia raviks rakendatava ravimi valmistamiseks - Google Patents

Enoksapariini kasutamine ajuisheemia raviks rakendatava ravimi valmistamiseks

Info

Publication number
EE200200374A
EE200200374A EEP200200374A EEP200200374A EE200200374A EE 200200374 A EE200200374 A EE 200200374A EE P200200374 A EEP200200374 A EE P200200374A EE P200200374 A EEP200200374 A EE P200200374A EE 200200374 A EE200200374 A EE 200200374A
Authority
EE
Estonia
Prior art keywords
enoxaparin
medicament
manufacture
treatment
cerebral ischemia
Prior art date
Application number
EEP200200374A
Other languages
English (en)
Inventor
Mary V�ronique
Stutzmann Jean-Marie
Uzan Andr�
Wahl Florence
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200200374A publication Critical patent/EE200200374A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200200374A 2000-01-06 2001-01-03 Enoksapariini kasutamine ajuisheemia raviks rakendatava ravimi valmistamiseks EE200200374A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000137A FR2803522B1 (fr) 2000-01-06 2000-01-06 Nouvelle application therapeutique de l'enoxaparine
PCT/FR2001/000014 WO2001049298A2 (fr) 2000-01-06 2001-01-03 Nouvelle application therapeutique de l"enoxaparine

Publications (1)

Publication Number Publication Date
EE200200374A true EE200200374A (et) 2003-12-15

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200374A EE200200374A (et) 2000-01-06 2001-01-03 Enoksapariini kasutamine ajuisheemia raviks rakendatava ravimi valmistamiseks

Country Status (30)

Country Link
EP (1) EP1248638B1 (et)
JP (1) JP2003519185A (et)
KR (1) KR20020069240A (et)
CN (1) CN1400905A (et)
AR (1) AR026804A1 (et)
AT (1) ATE344671T1 (et)
AU (1) AU784656B2 (et)
BR (1) BR0107442A (et)
CA (1) CA2396178A1 (et)
CZ (1) CZ20022303A3 (et)
DE (1) DE60124373T2 (et)
DK (1) DK1248638T3 (et)
EA (1) EA006035B1 (et)
EE (1) EE200200374A (et)
ES (1) ES2275648T3 (et)
FR (1) FR2803522B1 (et)
HK (1) HK1052649A1 (et)
HR (1) HRP20020573A2 (et)
HU (1) HUP0204040A3 (et)
IL (1) IL150477A0 (et)
MX (1) MXPA02006672A (et)
NO (1) NO20023243D0 (et)
NZ (1) NZ520283A (et)
PL (1) PL357192A1 (et)
PT (1) PT1248638E (et)
SK (1) SK9612002A3 (et)
UA (1) UA75587C2 (et)
WO (1) WO2001049298A2 (et)
YU (1) YU51802A (et)
ZA (1) ZA200205415B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR063530A1 (es) * 2006-10-30 2009-01-28 Aventis Pharma Sa Procedimiento de utilizacion de enoxaparina sodica para la preparacion de un medicamento
ITMI20091445A1 (it) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008595A1 (en) * 1992-10-13 1994-04-28 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Also Published As

Publication number Publication date
EA200200750A1 (ru) 2003-02-27
SK9612002A3 (en) 2002-12-03
EP1248638A2 (fr) 2002-10-16
FR2803522A1 (fr) 2001-07-13
FR2803522B1 (fr) 2004-01-02
DE60124373D1 (de) 2006-12-21
MXPA02006672A (es) 2002-09-30
YU51802A (sh) 2005-06-10
PT1248638E (pt) 2007-02-28
DE60124373T2 (de) 2007-08-30
AU784656B2 (en) 2006-05-18
CA2396178A1 (fr) 2001-07-12
CN1400905A (zh) 2003-03-05
NZ520283A (en) 2004-09-24
WO2001049298A2 (fr) 2001-07-12
NO20023243L (no) 2002-07-04
CZ20022303A3 (cs) 2002-11-13
WO2001049298A3 (fr) 2002-04-04
BR0107442A (pt) 2002-10-08
HK1052649A1 (zh) 2003-09-26
KR20020069240A (ko) 2002-08-29
DK1248638T3 (da) 2007-03-19
HUP0204040A2 (hu) 2003-04-28
ZA200205415B (en) 2003-10-13
JP2003519185A (ja) 2003-06-17
UA75587C2 (en) 2006-05-15
PL357192A1 (en) 2004-07-26
NO20023243D0 (no) 2002-07-04
HUP0204040A3 (en) 2003-05-28
EA006035B1 (ru) 2005-08-25
IL150477A0 (en) 2002-12-01
ES2275648T3 (es) 2007-06-16
AU3183001A (en) 2001-07-16
ATE344671T1 (de) 2006-11-15
EP1248638B1 (fr) 2006-11-08
AR026804A1 (es) 2003-02-26
HRP20020573A2 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
NO2020007I1 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
NO20034388D0 (no) Terapeutisk middel for kronisk artritt sykdommer i barne- relaterte sykdommer
IL183506A (en) Use of a compound for the preparation of a drug for the treatment of diseases of breast tumors
IL168279A (en) Use of liposomal and aminoglycoside composition to prepare a drug for the treatment or improvement of infection
IL183101A (en) Use of tetrahydrocannabivarin in drug production
DE60103621D1 (de) Vernetzbare oder polymerisierbare präpolymere
PT1294682E (pt) Derivados de acilfenilureia processo para a sua preparacao e sua aplicacao como medicamentos
IL170309A (en) Use of chondroitin sulfate in the preparation of a cure for cystitis
AR028622A1 (es) Derivados de tropano utiles en terapia
MXPA03005731A (es) Articulo absorbente que tiene tratamientos medicinales liberables.
IL187220A (en) Use of sodium arsenite sodium in the preparation of a drug for the treatment of metastatic tumor diseases
IS6891A (is) Aðferðir við gjöf epóþílon hliðstæðna við meðferðkrabbameins
EE200200214A (et) Dipüridamooli või mopidamooli kasutamine sellise ravimi valmistamiseks, mis on ette nähtud fibriinsõltuvate mikrotsirkulatsiooni häirete ennetamiseksja raviks
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
NO20050689L (no) Terapeutisk anvendelse
PT1248608E (pt) Substancias para usar no tratamento de psoriase
DE50209245D1 (de) Neuroprotektives medikament
EP1679070A4 (en) USE OF L-BUTYLPHTALIDE IN THE MANUFACTURE OF MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF CEREBRAL INFARCTION
EP1709962A4 (en) USE OF L-BUTYLPHTALIDE IN THE MANUFACTURE OF MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF BRAIN ISCHEMIA-INDUCED DISEASE
DE60222664D1 (de) Hautbehandlungsmittel
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
EE200200374A (et) Enoksapariini kasutamine ajuisheemia raviks rakendatava ravimi valmistamiseks
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
ATE286901T1 (de) Kristallin-therapeutisches mittel